New daily pill aims to boost growth in kids with dwarfism
NCT ID NCT07297875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called ABSK061 in children aged 3 to 12 with achondroplasia, a common form of dwarfism. The drug is taken once daily and aims to improve growth rate. The trial will first find a safe dose, then check how well it works over a year. About 110 children will take part across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ABSK061 (a drug taken orally once daily)
- What this could lead to
- If successful, this could lead to a daily treatment that helps children with achondroplasia grow more than they would without treatment.
- What could go wrong
- This is an early-phase trial with only 110 participants, so results may not apply to all. The drug may cause side effects or fail to improve growth significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACHONDROPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Children's Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
Chengdu Women's and Children's Central Hospital
Chengde, Sichuan, China
-
Children's Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
Henan Children's Hospital, Zhengzhou Children's Hospital
Zhengzhou, Henan, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, China
-
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a weekly shot help children with achondroplasia grow taller?
- Can growth hormone boost height in children with dwarfism?
- Weekly shot may boost growth in kids with dwarfism
- Experimental achondroplasia drug trial halted early
- No treatment, just tracking: PROPEL study watches how kids with achondroplasia grow
- New drug aims to boost height in kids with dwarfism